Provided by Parkinson & Movement Disorder Alliance

Technological advances are substantially altering the landscape for DBS treatment. This session explains key advances that characterize the field today, incorporating essential information for clinicians who use DBS or recommend it for their patients. Topics include remote programming, adaptive DBS, directional leads, closed-loop systems, rechargeable devices, and integration of existing systems with digital health tools.

Estimated time to complete activity: 30 minutes

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by PMD Alliance.  PMD Alliance is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physician Continuing Medical Education

PMD Alliance designates this course for a maximum of .5 AMA PRA Category 1 Credit(s)™.  

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

This course is for movement disorder specialists, neurologists, advanced practice providers, and other healthcare professionals involved in the care of patients with a movement or related disorder.

Educational Objectives

After completing this activity, the participant should be better able to:

• Analyze the clinical applications and limitations of current DBS technologies for managing Parkinson’s disease and other movement disorders
• Evaluate patient-specific factors to guide optimal DBS programming strategies
• Demonstrate how to integrate emerging DBS tools into clinical workflows to enhance treatment efficiency and patient quality of life

Faculty

Anvi Gadani, MD
Medstar Georgetown University Hospital

Dr. Anvi Gadani is a Neurologist subspecializing in Movement Disorders with special interest in Memory Disorders at MedStar Montgomery Medical Center, affiliated with MedStar Georgetown University. She completed her residency in Neurology at the University of Connecticut and completed her fellowship training at Georgetown University. Dr. Gadani’s clinical interests and expertise include Parkinson’s disease and other Movement Disorders, Memory Disorders, and botulinum toxin injections for conditions like dystonia and spasticity. Her philosophy of care is to “listen to the patient’s whole story and take into consideration each individual’s social and cultural background to make a shared decision about their medical care”.

Gary Volkell, DO
Medstar Georgetown University Hospital

Gary Volkell, DO, is a board-certified neurologist who is fellowship trained in movement disorders. He sees patients at MedStar Franklin Square Medical Center.

Dr. Volkell specializes in treatment for Parkinson’s disease, dystonia (including cervical dystonia/spasmodic torticollis), tardive dyskinesia, chorea, Huntington’s disease, tremor (including essential tremor), tics, Tourette’s syndrome, restless legs syndrome, REM-sleep behavior disorder, ataxia, and functional movement disorders. In addition to these movement conditions, Dr. Volkell also treats general neurologic concerns such as stroke, seizure, headache and migraines, memory issues, neuropathy, multiple sclerosis, myasthenia gravis, and Guillain-Barre syndrome.

Dr. Volkell is experienced in the latest neurologic innovations. He performs lumbar punctures; microelectrode recording and Deep Brain Stimulation (DBS) programming for conditions such as Parkinson’s disease, essential tremor, and dystonia; and Botulinum toxin injections for dystonia, cervical dystonia/spasmodic torticollis, spasticity, sialorrhea, blepharospasm, hemifacial spasm, and migraines. He has also worked in clinical trial research for diseases such as Parkinson’s disease and parkinsonism.

It is important to Dr. Volkell to get to know his patients long-term. He works collaboratively with his patients to solve neurologic problems, share his knowledge, and develop a personalized treatment plan so that his patients find relief.

Disclosure of Relevant Financial Relationships

Parkinson and Movement Disorder Alliance (PMD Alliance) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies.  PMD Alliance is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CME activity:

• Anvi Gadani, MD
• No disclosures to report
• Gary Volkell, DO
• No disclosures to report

Planners reported the following relevant financial relationships with ineligible entities related to the educational content of this CME activity:

• Leslie Cloud, MD
• Site investigator for research supported by Amneal and Intracellular Therapies
• Speakers’ Bureau, consultant, and/or advisory board member for Amneal

• Britt Stone, MD
• Speakers’ Bureau, consultant, and/or advisory board member for Boston Scientific

• Jason Rivera, MPH
• No disclosures to report

• Clarisse Goas, NP
• Principal or site investigator for research supported by AskBio
• Speakers’ Bureau, consultant, and/or advisory board member for Mitsubishi Tanabe Pharma America

• Anissa Mitchel, LCSW
• No disclosures to report

• Kelly Papesh, DNP
• Speakers’ Bureau, consultant, and/or advisory board member for Mitsubishi Tanabe Pharma America

• Mary Ann Chapman, PhD
• Consultant for Allergan Aesthetics

• Fernando Pagan, MD
• Site investigator for research supported by Amneal and Kyowa Kirin
• Other grant support from Medtronic
• Speakers’ Bureau, consultant, and/or advisory board member for AbbVie, Acadia, Amneal, Acorda, Kyowa Kirin, Teva, Supernus, Merz, and Neurocrine

• Yasar Torres-Yaghi, MD
• No disclosures to report

PMD Alliance has received non-CME educational funding and support from ineligible companies.  This support is not tied to continuing medical education.  These relationships have been mitigated and do not influence CME content.

All identified relevant financial relationships are thoroughly vetted and mitigated according to PMD Alliance CME Program standard operating procedures. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Commercial Support

This activity is supported by independent medical education grants from Merz, AbbVie, Kyowa Kirin, and Mitsubishi Tanabe Pharma America.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Request for Credit

In order to obtain your CME certificate, please follow the directions provided at the conclusion of the course.  

If you have questions regarding the certification of this activity, please contact PMD Alliance at education@pmdalliance.org